Gastroenterological complications of Anderson-Fabry disease

Curr Pharm Des. 2013;19(33):6009-13. doi: 10.2174/13816128113199990347.

Abstract

Fabry disease is a multisystemic X-linked lysosomal storage disorder, caused by the partial or complete deficiency of alpha-galactosidase A activity. The storage of glycosphingolipids in the vascular endothelium and in various tissues can lead to a broad spectrum of clinical manifestations. Renal failure, cardiovascular disease, and strokes are the main causes of morbidity and mortality. Gastrointestinal symptoms, although common, are often under-reported in the literature. This review covers the gastroenterological aspects of Fabry disease.

Publication types

  • Review

MeSH terms

  • Enzyme Replacement Therapy
  • Fabry Disease / complications*
  • Fabry Disease / diagnosis
  • Fabry Disease / metabolism
  • Fabry Disease / therapy
  • Female
  • Gastrointestinal Diseases / diagnosis
  • Gastrointestinal Diseases / etiology*
  • Gastrointestinal Diseases / metabolism
  • Gastrointestinal Diseases / therapy
  • Glycosphingolipids / metabolism
  • Humans
  • Male
  • Sex Characteristics
  • alpha-Galactosidase / administration & dosage
  • alpha-Galactosidase / blood
  • alpha-Galactosidase / therapeutic use

Substances

  • Glycosphingolipids
  • alpha-Galactosidase